NT 10-K

Filing

Greenwich LifeSciences, Inc. Filed 2024-04-01 Acc 0001493152-24-012370

Documents 1

NT 10-K , formnt10-k.htm

Around this filing

2025-03-31 NT 10-K NT 10-K
2024-04-03 4 CEO and CFO bought 3,000 shares at $19.08 ($57,240)
2024-04-01 NT 10-K NT 10-K
2024-03-26 4 CEO and CFO bought 2,500 shares at $19.98 ($49,950)

Link to a passage

External

SEC EDGAR (opens in new tab)